Abstract
Purpose
Acute graft-versus-host disease (GvHD) is a constant and severe complication after allogeneic stem cell transplantation regularly involving skin, liver, gut, and lungs. The cytokine interleukin-18 (IL-18) has been shown to increase in patients who develop acute GvHD after bone marrow tranplantation (BMT).
Materials and methods
Here, we measured IL-18 serum levels after peripheral blood stem cell transplantation (PBSCT) at several characteristic time points in 24 patients (median age 46 years). Patients received a median of 7.3×106/kg bodyweight CD34-positive blood stem cells from HLA-matched family donors (n=5), matched unrelated donors (n=18), and one mismatched unrelated donor. GvHD prophylaxis consisted of cyclosporin A alone or combined with methotrexate and/or mycophenolate mofetil.
Results
In 14 patients we observed no GvHD or only GvHD grade I whereas ten patients developed GvHD grade II–IV post transplant. Low, intermediate, and high levels of serum IL-18 were found in patients after allogeneic PBSCT independently of GvHD after transplantation. In contrast to GvHD arising after BMT, there was no clear correlation between absolute IL-18 serum levels and GvHD grade after PBSCT. However, the individual time course of IL-18 serum level after engraftment correlates with acute GvHD after PBSCT. In detail, an increase of serum IL-18 of at least 1.6-fold after engraftment is associated with acute GvHD II or higher with a sensitivity of three out of four. Using the 1.6 “cut-off” for IL-18 increase after engraftment, a specificity of up to 100% can be achieved.
Conclusion
The time course of IL-18 serum levels might be used for GvHD prediction after PBSCT comparable to absolute serum levels after BMT.
Similar content being viewed by others
References
Glucksberg H, Storb R, Fefer A, et al (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18:295–304
Poletti V, Salvucci M, Zanchini R, et al (2000) The lung as a target organ in patients with hematologic disorders. Haemotologica 85:855–864
Khurshid I, Anderson LC (2002) Non-infectious pulmonary complications after bone marrow transplantation. Postgrad Med J 78:257–262
Korngold R, Sprent J (1987) T-cell subset and graft-versus-host disease. Transplantation 44:335–339
Krenger W, Ferrara JLM (1996) Graft-versus-host disease and the Th1/Th2 paradigm. Immunol Res 15:50–73
Krenger W, Hill GR, Ferrara JLM (1997) Cytokine cascades in acute graft-versus-host disease. Transplantation 64:553–558
Antin JH, Ferrara JLM (1992) Cytokine dysregulation and acute graft-versus-host disease. Blood 80:2964–2968
Niederwieser D, Herold M, Woloszczuk W, et al (1990) Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages. Transplantation 50:620–625
Bonnotte B, Burdiles AM, Chehimi J, et al (1996) Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation. Eur Cytokine Netw 7:389–394
Okamura H, Tsutsui H, Komastu T, et al (1995) Cloning of a new cytokine that induces IFN- production by T cells. Nature 378:88–91
Dao T, Ohashi K, Kayano T, et al (1996) Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol 173:230–235
Okamoto I, Kohno K, Tanimoto T, et al (1999) Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12. J Immunol 162:3202–3211
Okamura H, Kashiwamura S, Tsutsui H, et al (1998a) Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol 10:259–264
Okamura H, Tsutsui H, Kashiwamura S, et al (1998b) Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol 70:281–312
Fantuzzi G, Puren AJ, Harding MW, et al (1998) Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta-converting enzyme (caspase-1)-deficient mice. Blood 91:2118–2125
Gu Y, Kuida K, Tsutsui H, et al (1997) Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 275:206–209
Aizawa Y, Akita K, Taniai M, et al (1999) Cloning and expression of interleukin-18 binding protein. FEBS Lett 26:338–342
Zecchina G, Novick D, Rubinstein M, et al (2001) Interleukin-18 binding protein in acute graft-versus-host disease and engraftment following allogeneic peripheral blood stem cell transplants. J Hematother Stem Cell Res 10:769–776
Fujimori Y, Takatsuka H, Takemoto Y, et al (2000) Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol 109:652–657
Reddy P, Ferrara JL (2003) Role of interleukin-18 in acute graft-vs-host disease. J Lab Clin Med 141:365–371
Reddy P, Teshima T, Kukuruga M, et al (2001) Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis. J Exp Med 194:1433–1440
Itoi H, Fujimori Y, Tsutsui H, et al (2001) Fas ligand-induced caspase-1-dependent accumulation of interleukin-18 in mice with acute graft-versus-host disease. Blood 98:235–237
Shankar G, Bryson JS, Jennings CD, et al (1998) Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation. Am J Respir Cell Mol Biol 18:235–242
Cooke KR, Krenger W, Hill G, et al (1998) Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation. Blood 92:2571–2580
Bensinger WI, Martin PJ, Storer B, et al (2001) Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers. NEJM 344:175–181
Flowers M, Parker PM, Johnston LJ, et al (2002) Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 100:415–419
Slavin S, Nagler A, Naparstek E, et al (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 3:756–763
Sevilla J, Gonzalez-Vicent M, Mader L, et al (2002) Early onset of acute immune-mediated lung injury in a child undergoing allogeneic peripheral blood transplantation. Am J Hematol 69:56–58
Arndt PG, Fantuzzi G, Abraham E (2000) Expression of interleukin-18 in the lung after endotoxinemia or hemorrhage-induced acute lung injury. Am J Respir Cell Mol Biol 22:708–713
Acknowledgments
We thank Anja Markusch for her contributions to patient characteristics and Ms. Herrmann and Ms. Franke who determined cellular subpopulations of grafts and CD34 content of transplants
Author information
Authors and Affiliations
Corresponding author
Additional information
S. Scholl and H. G. Sayer contributed equally to this work.
Rights and permissions
About this article
Cite this article
Scholl, S., Sayer, H.G., Mügge, LO. et al. Increase of interleukin-18 serum levels after engraftment correlates with acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation. J Cancer Res Clin Oncol 130, 704–710 (2004). https://doi.org/10.1007/s00432-004-0603-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-004-0603-6